Joint pain improvement in patients on etanercept therapy for moderate to severe psoriasis

被引：0
|
作者：
Tyring, Stephen [1 ]
Kricorian, Gregory [2 ]
Gordon, Kenneth [3 ]
Klekotka, Paul [2 ]
机构：
[1] Univ Texas Houston, Houston, TX USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2011年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB158 / AB158
页数：1
相关论文
共 50 条
  • [21] Effects of methotrexate and etanercept treatment in moderate and severe psoriasis
    Benites, Elizabeth
    Carrillo, Esmeralda
    Heras, Martha
    MEDICINE, 2022, 101 (45) : E31527
  • [22] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
    Tunca, M.
    Koc, E.
    Akar, A.
    Kurumlu, Z.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
  • [23] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
    Griffiths, Christopher E. M.
    Strober, Bruce E.
    van de Kerkhof, Peter
    Ho, Vincent
    Fidelus-Gort, Roseanne
    Yeilding, Newman
    Guzzo, Cynthia
    Xia, Yichuan
    Zhou, Bei
    Li, Shu
    Dooley, Lisa T.
    Goldstein, Neil H.
    Menter, Alan
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02): : 118 - 128
  • [24] Etanercept treatment is able to modulate apoptosis process in patients with moderate to severe psoriasis
    Lembo, Serena
    Megna, Matteo
    Caiazzo, Giuseppina
    Ayala, Fabio
    Balato, Nicola
    Balato, Anna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB30 - AB30
  • [25] Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case cohort analysis
    Perera, G.
    Fonia, A.
    Smith, C.
    Barker, J. N. W. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 26 - 27
  • [26] Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis
    Langley, Richard G.
    Kasichayanula, Sree
    Trivedi, Mona
    Aras, Girish A.
    Kaliyaperumal, Arunan
    Yuraszeck, Theresa
    Gibbs, John
    Gibbs, Megan
    Kricorian, Greg
    Paller, Amy S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 340 - 346
  • [27] The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients
    Young, Melodie S.
    Horn, Elizabeth J.
    Cather, Jennifer C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (01) : 9 - 13
  • [28] Etanercept and methotrexate combination therapy for the treatment of moderate to severe psoriasis: A retrospective multicentre study
    Munoz-Santos, Carlos
    Vidal, David
    Gomez-Vazquez, Mercedes
    Sola-Ortigosa, Joaquim
    Guilabert, Antonio
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 (04) : E147 - E148
  • [29] QUALITY OF LIFE IMPROVEMENT WITH ETANERCEPT IN PATIENTS WITH MODERATE/SEVERE PSORIASIS FROM CENTRAL AND EASTERN EUROPE, LATIN AMERICA AND ASIA
    Kemeny, L.
    Amaya, M.
    Cetkovska, P.
    Lee, W. R.
    Galimberti, L. R.
    Mahgoub, E.
    Rahman, M.
    Marshall, L.
    Tang, B.
    VALUE IN HEALTH, 2013, 16 (07) : A509 - A509
  • [30] Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast
    Bagel, Jerry
    Stolshek, Bradley S.
    Yang, Yue
    Kricorian, Gregory
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (04) : 378 - 383
12345